Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Hey! Dildos Sale in our Dildos Store!
Popular Articles

Can-Fite-Completed Patient Enrollment For The Phase II Trial In Psoriasis With CF101
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, has achieved yet another goal by completion of patients" enrollment in its phase II Psoriasis trial. Approximately 70 patients were enrolled to this study, randomized into 4 groups treated with 1, 2 and 4 mg of CF101 and placebo. Patients are taking the drug for 12 weeks plus 2 weeks of follow-up. The trial is being conducted in 10 sites in Israel and Europe. The company estimates to release study data on Q3 2009.
drugs without prescription
One Stop Breast Clinics Best For Women
High-quality one-stop breast clinics could be the most effective way to spot breast cancer early, a study published in the British Journal of Cancer * reveals today (Wednesday).
News of the day
Firms Tweak Benefit Plans In District Of Columbia And Baltimore Area
The Washington Post reports that "More Washington- and Baltimore-area employers are shifting health-insurance costs to workers, offering high-deductible health plans and imposing restrictions on prescription-drug coverage to save money in the recession, according to a new survey by area human res managers to be released today. But to keep good workers from jumping ship, according to the survey, more employers are offsetting the restrictions by beefing up other perks -- giving staff more flexibility in taking time off and working from home, and extending benefits to domestic partners."
Oncology

Idaho Technology Gains Army Approval Of Platinum Path™ Extraction Kit For Biological Pathogen Detection Program

Idaho Technology, Inc. has received the support of the U.S. Army Test and Evaluation Command (ATEC) for use of the Platinum Path™ Extraction Kit (PPEK) with the Joint Biological Agent Identification and Diagnostic System (JBAIDS). "The PPEK kit is designed to handle dozens of different sample types, replacing the need for multiple specialized kits. In addition, it offers vast improvements and efficiencies over previous sample preparation methods. Our kit results in a clean sample ready for analysis in less than 30 minutes, two to three times as fast as some other methods," said Deepika de Silva, vice president of biochemistry for Idaho Technology. Developed under the direction and cooperation of the Joint Program Executive Office for Chemical and Biological Defense - Chemical Biological Medical Systems (CBMS) Joint Project Management Office, the PPEK will provide a significant cost savings across all service branches through the elimination of redundant sample preparation kits. The Platinum Path Extraction Kit reduces the annual extraction kit costs by 42% and represents an 80% reduction in the logistics footprint. Additionally, the Platinum Path kit reduces the training requirement by as much as 20%, while delivering increased operational effectiveness and suitability when compared to the currently fielded five extraction kits. "The entire JBAIDS Program"s mission is about making our war fighters safe against biological weapons and pandemic viral threats. The addition of the PPEK makes that mission easier and reduces logistics which saves money and more importantly will save lives. Idaho Technology is proud of this program and the difference it is making for the Department of Defense and our country," said Todd Ritter, chief development officer for Idaho Technology. Idaho Technology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009